Clinical Trial: A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230106) titled 'A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer' on Nov. 13.

Brief Summary: This is a phase II, multicentre clinical study investigating HS-20093 or SHR2554 in combination with a Novel Hormonal Agent (NHA) for advanced prostate cancer. The trial comprises two cohorts.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Prostate Cancer

Intervention: DRUG: HS-20093 for Injection

HS-20093 for injection.

DRUG: SHR3680 Tablet

SHR3680 tablet.

DRUG: Abiraterone Tablet

Abiraterone tablet.

DRUG: SHR2554 Tablet

SHR2554 tablet.

DRUG: Enzalutamide Tablet

Enzalutamide tablet.

DRUG: Darotam...